Early study explores new drug MK-8189 for schizophrenia
NCT ID NCT02181803
First seen May 03, 2026 · Last updated May 12, 2026 · Updated 2 times
Summary
This early-stage study tested the safety and how the body processes the experimental drug MK-8189. It included 55 people: some with schizophrenia (taking the drug alone or with their usual medication) and some healthy volunteers. The main goal was to find a dose that is safe and well-tolerated, and to measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.